Benedetti Fabio M 4
4 · GERON CORP · Filed Jun 1, 2009
Insider Transaction Report
Form 4
GERON CORPGERN
Benedetti Fabio M
SVP, Chief Med Off, Oncology
Transactions
- Award
Common Stock
2009-05-29+25,000→ 80,560 total - Award
Stock Option (right to buy)
2009-05-29$6.52/sh+35,000$228,200→ 185,000 totalExercise: $6.52Exp: 2019-05-29→ Common Stock (35,000 underlying) - Sale
Common Stock
2009-05-29$6.35/sh−2,277$14,459→ 38,060 total - Award
Common Stock
2009-05-29+17,500→ 55,560 total
Footnotes (4)
- [F1]Shares sold in payment of payroll tax withholdings in connection with vesting of restricted stock award.
- [F2]The shares of restricted stock will remain subject to a repurchase right of Geron over four years, during such time the repurchase right will lapse with respect to 25% of such shares on each anniversary date of May 28, 2009. The lapse of Geron's repurchase right is conditioned on the employee continuing to provide services to Geron through each vesting date.
- [F3]The shares of restricted stock will remain subject to a repurchase right of Geron until May 28, 2010, at which time such repurchase right will lapse with respect to 25% of such shares. Geron's repurchase right will lapse with respect to the balance of the shares on May 28, 2011. The lapse of Geron's repurchase right is conditioned on the employee continuing to provide services to Geron through each vesting date.
- [F4]This option is exercisable in a series of 48 consecutive equal monthly installments commencing May 29, 2009 provided the optionee continues to provide services to the Company.